Datamonitor launches Global Healthcare Review
The Global Healthcare
Review contains news, analysis and opinion on the healthcare and
pharmaceutical industry. It covers all the major current business issues
and events from across the industry, including R&D, licensing deals,
alliances and joint ventures, and regulatory decisions.
Scope
-
Strategic insight
into the future shape of healthcare companies and markets
-
The most significant
healthcare industry news compiled into monthly updates, divided by
sector
-
Expert analysis into
the implications of the month's important healthcare industry events
-
Insight into the
future shape of the market for players at all levels
-
All the month's major
healthcare industry news in headline and summary form
Report Highlights
Out of the hundreds of
topics covered in this month's review, the most important include:
* Pfizer's takeover of
Pharmacia could be the first step in a wave of pharma industry
consolidation. Rivals such as GlaxoSmithKline, Aventis, AstraZeneca, Merck
and Bristol-Myers Squibb may have to follow suit, or risk being
overwhelmed.
* Schering-Plough faces a
battle to maintain its exclusivity to the Claritin treatment, after a US
District Court Judge found that certain claims of a patent protecting
against generic versions of the nonsedating antihistamine Claritin and
expiring in 2004 are not valid.
Reasons to Purchase
Not only keeps you
updated about industry events - it also gives you opinion and insight
Draws upon Datamonitor
analysts' extensive experience to bring you our perspective on the impact
of the latest events
Provides you with your
own news archive to track company and industry progress, giving you an
extensive reference to relevant events and issues
View
pdf brochure
Click
here to purchase online
